Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, investigator says.

When an impressive opening act at the professional level and strong performances at the U23 camp string together, a first ...

CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with ...

I Stayed at Palm Beach’s Most Instagrammed Hotel—Here’s What It Was Really Like first appeared on Parade on Jun 21, 2025 This ...

Pope Leo XIV has said there should be no tolerance in the Catholic Church for any type of abuse. Leo made his first public ...

Shahs of Sunset alum Lilly Ghalichi has just filed for divorce again from husband Dara Mir making this the 4th divorce filing ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...